RU96103577A - METHOD FOR TREATING SARCOMA KAPOSHI - Google Patents

METHOD FOR TREATING SARCOMA KAPOSHI

Info

Publication number
RU96103577A
RU96103577A RU96103577/14A RU96103577A RU96103577A RU 96103577 A RU96103577 A RU 96103577A RU 96103577/14 A RU96103577/14 A RU 96103577/14A RU 96103577 A RU96103577 A RU 96103577A RU 96103577 A RU96103577 A RU 96103577A
Authority
RU
Russia
Prior art keywords
kaposhi
treating sarcoma
sarcoma
administered
prospidine
Prior art date
Application number
RU96103577/14A
Other languages
Russian (ru)
Other versions
RU2130773C1 (en
Inventor
Р.Х. Чилингиров
В.А. Молочков
Н.Ю. Краснощекова
Original Assignee
Московский областной научно-исследовательский клинический институт
Filing date
Publication date
Application filed by Московский областной научно-исследовательский клинический институт filed Critical Московский областной научно-исследовательский клинический институт
Priority to RU96103577A priority Critical patent/RU2130773C1/en
Priority claimed from RU96103577A external-priority patent/RU2130773C1/en
Publication of RU96103577A publication Critical patent/RU96103577A/en
Application granted granted Critical
Publication of RU2130773C1 publication Critical patent/RU2130773C1/en

Links

Claims (2)

1. Способ лечения саркомы Капоши путем последовательного введения проспидина с другим лекарственным средством, отличающийся тем, что в лимфатическую систему вводят проспидин в дозе 50 - 150 мг в сочетании с ингибитором протеолиза в дозе 10000 - 100000 ЕД на одну процедуру через день 10 - 15 раз на курс лечения.1. A method for the treatment of Kaposi’s sarcoma by sequential administration of prospidin with another drug, characterized in that prospidine is administered at a dose of 50-150 mg in combination with a proteolysis inhibitor at a dose of 10,000-100,000 units per procedure every other day 10-15 times on a course of treatment. 2. Способ по п. 1, отличающийся тем, что дополнительно вводят подкожно 16 - 48 ЕД лидазы, при этом проспидин и ингибитор протеолиза вводят лимфотропно. 2. The method according to p. 1, characterized in that it is additionally administered subcutaneously with 16 to 48 units of lidase, while prospidine and a proteolysis inhibitor are administered lymphotropically.
RU96103577A 1996-02-29 1996-02-29 Method for treating the cases of kaposi sarcoma RU2130773C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU96103577A RU2130773C1 (en) 1996-02-29 1996-02-29 Method for treating the cases of kaposi sarcoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU96103577A RU2130773C1 (en) 1996-02-29 1996-02-29 Method for treating the cases of kaposi sarcoma

Publications (2)

Publication Number Publication Date
RU96103577A true RU96103577A (en) 1998-05-20
RU2130773C1 RU2130773C1 (en) 1999-05-27

Family

ID=20177311

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96103577A RU2130773C1 (en) 1996-02-29 1996-02-29 Method for treating the cases of kaposi sarcoma

Country Status (1)

Country Link
RU (1) RU2130773C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2684606C1 (en) * 2017-11-29 2019-04-10 Федеральное государственное бюджетное образовательное учреждение высшего образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СибГМУ Минздрава России) Method of combined treatment of non-small-cell lung cancer

Similar Documents

Publication Publication Date Title
KR950002785A (en) Parathyroid hormone and raloxyphene to increase bone mass
EA200200392A1 (en) THE METHOD OF OBTAINING EXTRACT FROM PLANTS OF TRICHOCAULON OR HODIA GENERA;
KR930007441A (en) medicine
RU94002133A (en) 6-CHLOR-5-FTOR-3- (2-TENOIL) -2-OXINDOL-1-CARBOXAMIDE AS AN ANALOGESIC AND ANIMATERATIVE MEDICATION
CA2283255A1 (en) Use of r-nsaid's for the prevention of alzheimer's disease
RU2001124802A (en) The use of saredutant and its pharmaceutically acceptable salts for the preparation of medicines used to treat or prevent mood disorders, adaptation disorders or mixed anxiety-depressive disorders
RU96103577A (en) METHOD FOR TREATING SARCOMA KAPOSHI
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
RU2003100517A (en) NEW INTERFERON FOR THE TREATMENT OF MULTIPLE SCLEROSIS
KR900017599A (en) Pharmaceutical composition for tumor treatment
RU2000117991A (en) METHOD FOR TREATMENT OF LONG-TERM, REDICATIVE FORMS OF PSEUDOTUBERCULOSIS AND ITS SPECIFIC COMPLICATIONS IN CHILDREN
RU93027489A (en) METHOD OF SURGICAL CORRECTION OF CHRONIC DISORDERS OF DUODENAL PASSIBILITY
RU2001135669A (en) Method for regional anesthesia for severe skeletal trauma of the lower limb
RU97117735A (en) METHOD FOR TREATING DIPHTERIA
RU99119306A (en) METHOD FOR TREATING LARGE-SIZED Bronchial Fistulas Using Submucosal Injections
RU96107091A (en) METHOD FOR SEPTIC SHOCK TREATMENT IN PERITONITIS
RU2000117903A (en) METHOD FOR TREATING CHRONIC GASTRITIS AND DUODENAL ULCER
RU96122672A (en) ECHINAMAX. METHOD OF TREATMENT OF ASTHENIC CONDITIONS IN PHYSIOGENIC DISADAPTATIONS
RU2000111645A (en) METHOD FOR TREATING HEMORRHAGIC FEVER WITH RENAL SYNDROME
KR920011482A (en) Use of heptastigmine in treating brain attacks
RU95115404A (en) APPLICATION OF RILUZOLE AS A MEANS FOR THE TREATMENT OF PARKINSON'S DISEASE AND PARKINSON'S SYNDROMES, METHOD FOR PRODUCING A MEDICINE
RU99122488A (en) METHOD FOR TREATING CANCER ENDOMETRY
RU94037731A (en) Method for treating multiple sclerosis
RU98109810A (en) METHOD FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS
RU93014293A (en) METHOD OF TREATMENT OF CHRONIC BRONCHITIS